CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 50 enrolled
Drug / intervention
Bupivacaine-fentanyl +4 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02988219
NCT02988219Phase 4Completed
CompareCT.gov

Evaluation of Cardiac Arrhythmias in Patients Undergoing Kidney Cancer Surgery Depending on the Anaesthesia Method

Medical University of Warsaw·interventional·Posted Dec 9, 2016·Updated May 30, 2017

In Brief

A Phase 4 clinical trial evaluating Bupivacaine-fentanyl, Holter ECG monitor, and 3 other interventions for Arrhythmia, Cardiac and 3 related conditions. Completed, enrolled 50 participants across 1 site.

Detailed Summary

This study evaluates the incidence of cardiac arrhythmias during the perioperative period in patients undergoing open kidney cancer surgery in the lateral position. All the participants will be randomly allocated to receive general (Group G) or combined epidural/general anaesthesia (Group G/E). The anaesthetic technique is standardized. The Holter monitor will be applied at the evening before the surgery, tracing continuously for a period of 24 hours (7PM-7PM)

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArrhythmia, Cardiac, Kidney Cancer, Surgery, Anesthesia, Local
CountriesPoland
Collaborators--

Timeline

Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedDec 9, 2016
Enrollment StartJun 1, 2010
Primary CompletionDec 1, 2014
Study CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 4.5 yearsPosted 9.6 years ago

Interventions

Bupivacaine-fentanyldrug

Local anesthetic

Holter ECG monitordevice

3-chanel, CM5 leads

Open kidney cancer surgeryprocedure

Lateral position

General anesthesiaprocedure

Epidural Anaesthesiaprocedure